Remove Clinical Trials Remove Genetic Analysis Remove Life Science
article thumbnail

Solving the Global Clinical Trial Gap: The Case for Partnering with Multisite Lab Services

XTalks

With this has come an increase in the size of the global clinical trials market, with an estimated worth of around $46.8 The lab has processed over 25,000 samples, participated in almost 60 clinical trials, and has partnered with over 25 different pharmaceutical companies. trillion, with oncologics accounting for $99.5

article thumbnail

International Women’s Day 2024: A Spotlight on 5 Women’s Health Webinars with Xtalks

XTalks

Experts discuss the therapeutic landscape, treatment gaps, regulatory considerations and clinical trial strategies. The webinar provides insights into a novel method that facilitates detailed genetic analysis of breast cancer, marrying the depth of whole-genome studies with the precision of targeted analysis at the single-cell level.

Genetics 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bridging Gaps in Rare Disease Clinical Trials: Insights from Collaborative Success in Pompe Disease Research

XTalks

Orphan drug development poses many challenges that are unique to rare diseases, including recruitment in small patient populations, variable progression with heterogenous clinical manifestations and limited understanding of disease progression and natural history.

article thumbnail

Top 10 Biotech Trends for 2025

XTalks

For example, antisense oligonucleotide (ASO)-based therapies have gained traction, with 100 Phase I clinical trials initiated and around 25 percent of these advancing to Phase II or Phase III trials in recent years. The global NGS market is projected to grow from $13.0 billion in 2022 to $27.0 percent over this period.